High Tide – HITI Stock Analysis and HITI Price Target

Sanofi CEO Paul Hudson pitches 12 blockbusters in a bid to convince investors on boosting R&D spend

Four years ago, Paul Hudson welcomed investors and analysts to Sanofi’s Cambridge, MA office, introducing his strategy for the French pharma giant. Hudson, who joined

December 8, 2023

Judge skeptical of arguments against Medicare drug price negotiation

WILMINGTON, Del. — Wednesday was the first time that a federal judge asked questions in-person of drug industry lawyers who are trying to stop Medicare

January 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.